By surveying previous studies that profiled gene expression in OSCC (Cromer et al., 2004; Ginos et al., 2004; Sengupta et al., 2006; Ye et al., 2008; Estilo et al., 2009; Peng et al., 2011b), we found significantly elevated expression of MASTL in tumor samples, in comparison to normal controls (Figure 1A). The gene discussed is MASTL; the disease is neoplasm.